Senti Biosciences (SNTI) Depreciation and Depletion (2021 - 2025)
Senti Biosciences' quarterly Depreciation and Depletion came in at $893000.0 in Q4 2025, down 4.7% year-on-year from $937000.0 in Q4 2024, and down 1.22% quarter-over-quarter from $904000.0 in Q3 2025.
Senti Biosciences has reported Depreciation and Depletion for 5 years, with the latest figure at $893000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation and Depletion fell 4.7% year-over-year to $893000.0; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (down 4.82% YoY), and the FY2025 full-year result was $3.6 million, down 5.24% from the prior year.
- Depreciation and Depletion for Q4 2025 stood at $893000.0, down from $904000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $1.3 million in Q3 2023, with the low at $200000.0 in Q2 2021.
- Average Depreciation and Depletion over 5 years is $685578.9, with a median of $893000.0 recorded in 2025.
- Year-over-year, Depreciation and Depletion soared 225.0% in 2023 and slumped 30.77% in 2024.
- Tracing SNTI's Depreciation and Depletion over 5 years: stood at $257000.0 in 2021, then jumped by 75.88% to $452000.0 in 2022, then surged by 119.47% to $992000.0 in 2023, then fell by 5.54% to $937000.0 in 2024, then declined by 4.7% to $893000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $893000.0 (Q4 2025), $904000.0 (Q3 2025), and $914000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 893,000.00 |
| Dec 31, 2025 | 893,000.00 |
| Sep 30, 2025 | 904,000.00 |
| Sep 30, 2025 | 904,000.00 |
| Jun 30, 2025 | 914,000.00 |
| Jun 30, 2025 | 914,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Dec 31, 2024 | 937,000.00 |
| Dec 31, 2024 | 937,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 984,000.00 |
| Mar 31, 2024 | 984,000.00 |
| Dec 31, 2023 | 992,000.00 |
| Dec 31, 2023 | 992,000.00 |
| Sep 30, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Mar 31, 2023 | 467,000.00 |
| Mar 31, 2023 | 467,000.00 |
| Dec 31, 2022 | 452,000.00 |
| Dec 31, 2022 | 452,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |